SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001104659-17-075718
Filing Date
2017-12-29
Accepted
2017-12-29 17:25:30
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-1 a17-29039_1s1.htm S-1 388347
2 EX-5.1 a17-29039_1ex5d1.htm EX-5.1 11336
3 EX-23.1 a17-29039_1ex23d1.htm EX-23.1 2332
4 EX-24.1 a17-29039_1ex24d1.htm EX-24.1 21107
5 GRAPHIC g290391kei001.gif GRAPHIC 3371
6 GRAPHIC g290391kei002.jpg GRAPHIC 748
7 GRAPHIC g290391kei003.jpg GRAPHIC 751
8 GRAPHIC g290391boi001.gif GRAPHIC 2966
9 GRAPHIC g290391bei001.gif GRAPHIC 2966
  Complete submission text file 0001104659-17-075718.txt   439873
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-222374 | Film No.: 171282738
SIC: 2834 Pharmaceutical Preparations